Paranova A/S v Merck & Co., Inc, Merck, Sharp & Dohme B.V. and MSD (Norge) A/S
INTA Position: INTA argued that a trademark proprietor has legitimate reasons to object to repackaging by a parallel importer where a connection to the parallel importer and damage to the trademark could be established
Outcome: The European Free Trade Association Court held that legitimate reasons to object to repackaging of pharmaceutical products may exist where changes to packaging are liable to damage the trademark's reputation
Glaxo Group Limited v. Dowelhurst Limited and Swingward Limited
INTA Position: A parallel importer should be entitled to make only the minimum changes to the packaging necessary to maintain the principle of the free movement of goods. Changes to packaging should not be permitted to damage the assurance of quality or the brand image of the trademark owner.
Outcome: The European Court of Justice held that a trademark owner may rely on its trademark rights to prevent a parallel importer from repackaging pharmaceutical products unless the exercise of those rights contributes to a restriction of trade.